Company news
Collegium Pharmaceutical, Inc. news in 2024
Collegium Pharmaceutical, Inc.'s news releases, calls and decks from 2024, newest first.
Collegium Reports Record Third Quarter 2024 Financial Results
November 6, 2024
Collegium Appoints Vikram Karnani as Chief Executive Officer
November 6, 2024
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
October 23, 2024
Collegium Completes Acquisition of Ironshore Therapeutics
September 3, 2024
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
August 29, 2024
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
August 27, 2024
Collegium Reports Second Quarter 2024 Financial Results
August 7, 2024
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
July 28, 2024
Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
July 24, 2024
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
June 12, 2024
Collegium to Participate in Jefferies Global Healthcare Conference
May 28, 2024
Collegium Announces $35 Million Accelerated Share Repurchase Program
May 12, 2024
Collegium Reports First Quarter 2024 Financial Results
May 8, 2024
Collegium Announces CEO Transition
May 8, 2024
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
April 28, 2024
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
April 24, 2024
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
April 10, 2024
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
April 2, 2024
Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
February 21, 2024
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
February 7, 2024
Collegium Provides 2024 Financial Guidance
January 2, 2024
Calls in 2024
- Collegium Pharmaceutical (NASDAQ:COLL) Q3 2024 Earnings Call
Nov 7, 2024
Transcript - Collegium Pharmaceutical (NASDAQ:COLL) Q2 2024 Earnings Call
Aug 8, 2024
Transcript - Collegium Pharmaceutical (NASDAQ:COLL) Q1 2024 Earnings Call
May 9, 2024
Transcript - Collegium Pharmaceutical (NASDAQ:COLL) Q4 2023 Earnings Call
Feb 22, 2024
Transcript
Decks in 2024
- Q3 2024 Earnings Presentation
Earnings · 23 slides · Nov 7, 2024
- Investor Presentation (September 2024)
Investor deck · 45 slides · Sep 4, 2024
- Q2 2024 Earnings Presentation
Earnings · 23 slides · Aug 8, 2024
- Merger or Acquisition (July 2024)
Merger or acquisition · 13 slides · Jul 29, 2024
- Q1 2024 Earnings Presentation
Earnings · 24 slides · May 9, 2024
- Q4 2023 Earnings Presentation
Earnings · 24 slides · Feb 22, 2024
- Investor Presentation (January 2024)
Investor deck · 37 slides · Jan 3, 2024